Arvaya Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....

Date: 06.08.2026 The Secretary, Listing Department Bombay Stock Exchange Ltd Phiroze Jeejeebhoy Towers, Street, Mumbai – 400 001 Scrip Code: 524723 Reference: ISIN: INE491D01017 Subject: Prior intimation of the Board Meeting pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Respected Authorities, Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("SEBI Listing Regulations"), we wish to inform that a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 12, 2026 to inter-alia, consider and approve: 1. To consider and approve material related party transaction(s) of the Company. 2. To consider and approve the appointment of CS Guinea Agrawal as Company Secretary of Arvaya Healthtech & Wellness Private Limited, a subsidiary of the Company. 3. To consider and approve the appointment of Mr. Rahul Ravindra Mayur as Non-Executive Independent Director on the Boards of Arvaya Healthtech & Wellness Private Limited, Health Secure Hospitals Private Limited and Tec-Pool Solutions Private Limited, being Wholly Owned Subsidiaries of the Company. 4. To consider and adopt the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June, 2026. 5. To consider and approve the Annual Secretarial Compliance Report of the Company for the financial year ended 31st March, 2026. 6. To take note of the Secretarial Audit Report of the Company for the financial year ended 31st March, 2026. 7. To consider and approve the calling of the Annual General Meeting of the Company. 8. To consider and approve the appointment of Scrutinizer for the e-voting process in relation to the ensuing Annual General Meeting. 9. To consider and approve the Directors' Report of the Company for the financial year ended 31st March, 2026. 10. To consider and approve the appointment of Mr. Abhiram Ranganath as Director on the Board of Wholly Owned Subsidiary. 11. To consider and approve the Management Discussion and Analysis Report of the Company for the financial year ended 31st March, 2026. 12. To consider and approve the appointment of Mr. Salil Shetty as Director on the Board of Wholly Owned Subsidiary. Further, with reference to our earlier communication dated 22nd June, 2026, the Trading Window for dealing in the securities of the Company has been closed with effect from 1st July, 2026 and shall remain closed until 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter ended 30th June, 2026. We request you to kindly take the same on your record and oblige. Thanking you. Yours faithfully, FOR AND ON BEHALF OF ARVAYA HEALTHCARE LIMITED (Formerly known as Bijoy Hans Limited) Kaushal Shah Managing Director DIN: 02175130 Place: Pune